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Abstract
Background: Poor semen quality is one of the main causes of infertility. We have generated a set of monoclonal
antibodies to human sperm and used them to investigate sperm quality. Some of these antibodies found
differences in the expression of proteins between normal sperm and pathological sperm displaying severe defects.
One of them was the Hs-14 antibody.
The aim of this paper was to determine the target protein of the Hs-14 monoclonal antibody and to investigate the
expression of the Hs-14-reacting protein on the sperm of asthenozoospermic men with sperm motility defect and
of healthy normozoospermic men.
Methods: Indirect immunofluorescence, one-dimensional and two-dimensional polyacrylamide gel electrophoresis,
immunoblotting and mass spectrometry.
Results: The Hs-14 antibody binds fibronectin, β-tubulin and valosin-containing protein - new name for this protein
is transitional endoplasmic reticulum ATPase (TERA). Since the Hs-14 reaction with TERA remained the strongest at
the highest antibody dilution, and Hs-14 consistently labelled the same spot or band as the monospecific anti-TERA
antibody on immunoblots, we assume that TERA is an Hs-14-specific protein. Binding of fibronectin and β-tubulin
might represent nonspecific cross-reactivity or Hs-14 reaction with similar epitopes of these proteins.
A significant difference (P < 0.001) in immunofluorescence staining with Hs-14 was found between the normozoospermic
and asthenozoospermic men.
Conclusion: The Hs-14 antibody enables discrimination between sterile or subfertile asthenozoospermic and
fertile normozoospermic men. Decreased levels of TERA in men can be used as a biomarker of reduced fertility.
Keywords: Acrosome, Human spermatozoa, Monoclonal antibody, Asthenozoospermia, Transitional endoplasmic
reticulum ATPase
* Correspondence: jana.peknicova@ibt.cas.cz
1Laboratory of Reproductive Biology, Institute of Biotechnology AS CR, the
Czech Academy of Sciences, v.v.i., Videnska 1083, 142 20 Prague 4, Czech
Republic
Full list of author information is available at the end of the article
© 2015 Capkova et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Capkova et al. Basic and Clinical Andrology  (2015) 25:11 
DOI 10.1186/s12610-015-0025-0
Résumé
Introduction: La pauvre qualité de la semence est l’une des causes d’infertilité. Nous avons généré une série
d’anticorps monoclonaux contre le sperme humain et nous l’avons utilisée pour examiner la qualité du sperme.
Certains de ces anticorps ont montré des différences d’ expression des protéines entre le sperme normal et le
sperme pathologique qui a des défauts sévères. L’un d’eux a été l’anticorps Hs-14. Le but de cet article était de
déterminer la protéine cible de l’anticorps monoclonal Hs-14 et d’établir l’expression de la protéine réagissant avec
Hs-14 sur le sperme des hommes asthénozoospermiques qui ont des défauts de la mobilité du sperme et sur celui
des hommes normozoospermiques.
Méthodes: Immunofluorescence indirecte, electrophorèse sur gel polyacrylamide à une ou deux dimensions,
immunoblotting et spectrométrie de masse.
Résultats: L’anticorps Hs-14 s’attache à la fibronectine, à la β-tubuline et à la protéine TERA (ATPase transitoire de
réticulum endoplasmique). Etant donné que la réaction du Hs-14 avec TERA a été la plus forte à la dilution la plus
grande de l’anticorps, et que Hs-14 marquait systématiquement la même tache ou bande que l’anticorps mono-
spécifique anti-TERA sur les immunoblots, nous supposons que TERA est une protéine spécifique pour Hs-14.
L’attachement à la fibronectine et à la β-tubuline pourrait représenter une réaction croisée non spécifique ou la
réaction du Hs-14 avec des épitopes similaires de ces protéines. Une différence significative (P < 0.001) en
immunofluorescence avec Hs-14 a été révélée entre hommes normozoospermiques et asthénozoospermiques.
Conclusions: L’anticorps Hs-14 permet de différencier les hommes stériles ou subfertiles asthénozoospermiques
des hommes fertiles normozoospermiques. Les niveaux de la TERA chez les hommes pourraient être utilisés comme
un marqueur biologique d’une fertilité réduite.
Motsclés: Acrosome, Spermatozoïdes humaines, Anticorps monoclonal, Asthénozoospermie, Transitoire ATPase de
réticulum endoplasmique
Background
Antibodies to human sperm proteins and seminal
plasma proved to be useful tools for the sperm quality
assessment, and consequently for the prognosis of suc-
cessful fertilization of eggs. In IVF clinics, semen quality
is routinely assessed by the concentration, morphology
and motility of spermatozoa, as it is given in WHO
guidelines [1]. Nevertheless, to better understand the
fertility problems, more complex analysis of the expres-
sion of individual proteins and their function in the
sperm processes, e,g. changes of individual proteins dur-
ing the acrosomal reaction, capacitation and other pro-
cesses, is needed [2–7].
Employment of antibodies thus elevated evaluation of
sperm ejaculates to the level of investigation of individ-
ual proteins relevant for the sperm function. Using the
set of monoclonal antibodies that we generated in our
laboratory we were able to perform a systematic and
continuous analysis of ejaculates for the needs of assisted
reproduction. These antibodies can detect poor quality
sperm samples even in cases when the parameters of
ejaculates meet the requirements of WHO classification
for normozoospermics. For example, our antibodies Hs-8,
Hs-14 and Hs-36 reliably bound to the acrosomes of
spermatozoa in normozoospermic men (60–80 % cells la-
belled), while their binding was lower in ejaculates with
pathological spermiograms (30–40 % cells labelled) [8].
The ability of our anti-acrosomal antibodies to recognize
defective spermatozoa was confirmed by assessment
of sperm in the mice that were exposed to pollutants
[9, 10]. Both findings undoubtedly suggest the import-
ance of the detected proteins in fertilization. The
condition when a semen sample complies with the
WHO requirements and still is not able to achieve
fertilization is not exceptional. In some cases, the ex-
pression of certain proteins is altered compared to
normal sperm [11] and antibodies represent an appro-
priate tool to detect the changes in the expression of
specific proteins [12]. However, the sperm quality as-
sessment cannot be based on a single protein. Our
experience with the Hs-16 monoclonal antibody that
detects secretory actin-binding protein (SABP) [13]
demonstrated that some normozoospermic samples
might display high expression of SABP, whose pres-
ence on spermatozoa is associated with sperm path-
ology [13]. It is obvious that sperm testing must be
comprehensive—optimally using a panel of antibodies.
Recently, great possibilities in this respect have been
offered by proteomics, where two-dimensional gels
enable simultaneous evaluation of hundreds of pro-
teins and provide a complex picture of the investi-
gated sample [14–16].
Comparison between 2D electrophoretic gels of nor-
mal and pathological sperm allowed us to select proteins
or groups of proteins whose changes in the expression
can be a signal of pathological condition [17, 18].
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Employment of monoclonal antibodies as a diagnostic
tool is dependent on the definition of antibody specifi-
city. The aim of our work was to characterize the Hs-14
monoclonal antibody, i.e., to investigate its target protein




Human ejaculates were obtained with the participants’
consent from the Centre of assisted reproduction
ISCARE I.V.F. (Prague, Czech Republic). All men (of age
25–40 years) gave their written informed consent with
donating the sperm ejaculates for the purposes of the re-
search project. The study was also approved by the insti-
tutional review board at the Institute of Biotechnology.
Thirty sperm samples from men with normal spermio-
grams and 30 samples from men with asthenozoosper-
mia with reduced motility (<40 %) were assessed. The
evaluation of semen density, motility and morphology
was carried out in compliance with the World Health
Organization standards (2010) [1].
Sperm sample from each men was independently re-
peated three times. The results were comparable and
therefore one of them was chosen for presentation.
Preparation of Hs-14 monoclonal antibody
The Hs-14 monoclonal antibody (mAb) was generated by
standard hybridoma technology introduced to the labora-
tory by Peknicova et al. [19], after immunization of BALB/c
mice with the acid extract of human sperm and fusion with
SP2/0-Ag14 myeloma cells (Sigma, Prague, Czech Republic).
The acid extract was prepared from the ejaculate of a nor-
mozoospermic donor (6 × 107 cells/ml, 60 % motility) as
follows: the ejaculate was centrifuged at 200 × g and the
sperm pellet was resuspended and washed three times in
phosphate-buffered saline (PBS, 150 mM NaCl, 17.7 mM
NaH2(PO4).2H2O, pH 7.4). The cell pellet was then ex-
tracted in 3 % (v/v) acetic acid, 10 % (v/v) glycerol, 30 mM
benzamidine for 16 h after cooling at 4 °C with permanent
rotation. The extract was dialyzed against 0.2 % acetic acid
and lyophilized.
Positive clones were selected by enzyme-linked im-
munosorbent assay (ELISA) [20] and indirect immuno-
fluorescence test [13, 21]. The Mouse Monoclonal
Antibody Isotyping Reagents (ISO-2, Sigma, Prague,
Czech Republic) were used to determine the immuno-
globulin class of the monoclonal antibody according to
the manufacturer’s instructions.
Antibodies
Besides the Hs-14 monoclonal antibody the following
antibodies were used: Prog.13 against progesterone
(mouse IgG) prepared in our laboratory [22], TU-06
against the N-terminal domain of β-tubulin (mouse
IgM) [23], TU-01 against the N-terminal domain of α-
tubulin (mouse IgG1) [24] and ab11433 against valosin-
containing protein (transitional endoplasmic reticulum
ATPase), (mouse IgG, Abcam, UK).
Purified tubulin
Microtubule protein from porcine brain was prepared
according to Shelanski et al. [25]. The entire procedure
of tubulin preparation was described in detail by Draber
et al. [26]. For preparation of the gel and sodium dodecyl
sulphate (SDS) sample of tubulin we used SDS cat.no.
L5750 (Sigma, Prague, Czech Republic), which makes
possible better separation of α- and β-tubulin.
Immunocytochemistry
Indirect immunofluorescence was carried out with human
spermatozoa. Samples were washed twice with PBS and
centrifuged at 200 × g for 10 min. Washed cells were di-
luted in PBS to a final concentration of 2 × 107 cells/ml
and 10 μl drops were smeared onto glass slides. Al-
ternatively, spermatozoa were diluted to a final con-
centration of 1 × 106 /ml and 10 μl drops were loaded
on glass slides. Smears or drops were air-dried and
then fixed and permeabilized with acetone for 10 min
at room temperature (RT, 23 °C). Slides were rinsed
in PBS, blocked in PBS-0.05%Tween + 1 % bovine
serum albumin + 10 % normal goat serum for 3 h at
RT and incubated in a humid chamber with the Hs-
14 mAb (undiluted hybridoma supernatant, immuno-
globulin concentration <20 μg/ ml) for 60 min at 37 ° C.
As a negative control, undiluted supernatant of Sp2/0
myeloma cells was used. After three washes in PBS the
slides were incubated with fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse IgM (μ − chain spe-
cific) immunoglobulin (Sigma, Prague, Czech Republic)
diluted 1:128 in PBS for 1 h at 37 °C. Then the slides were
washed in PBS, rinsed in deionized water, quickly air-
dried, dropped with mounting medium Vectashield con-
taining DAPI for DNA visualization (Vector Laboratories,
Burlingame, CA, USA) and covered with a cover glass.
Slides were stored at +4 °C until inspection. In immuno-
fluorescent test 200 cells were evaluated for each sample
and each sample was repeated 3 times.
Samples were examined with a Nikon Eclipse E400
fluorescent microscope with Nikon Plan Apo VC oil 60×
objective and photographed with CCD camera VDS1300
(Vosskühler, Osnabrück, Germany) with the aid of the
NIS elements AR imaging software (Laboratory Imaging,
Prague, Czech Republic). Some immunofluorescent
samples were also examined with confocal microscope
Olympus FV-1000, where digitized images of serial optical
3 μm-thick sections of spermatozoa were collected.
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Electrophoresis, western blotting and immunodetection
Unless otherwise indicated, all chemicals for sample prep-
aration, electrophoresis, blotting and immunodetection
were purchased from Sigma (Prague, Czech Republic).
Sample preparation
In all electrophoretic experiments, samples from normal
sperm were used. Ejaculated spermatozoa were washed
three times in PBS and used for protein extraction. For
one-dimensional polyacrylamide gel electrophoresis (1D
PAGE), a dry sperm pellet (1 × 108 cells) was resus-
pended in 100 μl of non-reducing 2× SDS sample buffer
[27] and heated in boiling water bath (3 min). After
cooling in + 4 °C and centrifugation (23,100 × g, 5 min,
4 °C), the supernatant was divided into aliquots and kept
at -80 °C until electrophoresis. To observe the migration
of proteins under reducing conditions, samples were
supplemented with β −mercaptoethanol (5 % final con-
centration) and heated for 1 min in boiling water bath
prior to electrophoresis.
Sperm cells (1× 108) were resuspended in 100 μl of rehy-
dration buffer (RHB, 7 M urea, 2 M thiourea, 4 % CHAPS,
1 % Triton X-100, 20 mM Tris) or 1 % Triton X-100.
For two-dimensional gel electrophoresis (2D PAGE),
sperm cells (1 × 108 cells) were resuspended in 100 μl of
RHB and extracted for 1 h at room temperature with oc-
casional shaking. Then the samples were centrifuged
(23,100 × g, 5 min, RT), and supernatants were aliquoted
and stored at −80 °C for subsequent analysis.
Sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS PAGE) and Western Blotting (WB)
Polyacrylamide gel electrophoresis in the presence of
SDS (SDS PAGE) was performed according to the
method of Laemmli [27]. Aliquots of non-reduced or re-
duced extracts corresponding to 10 μg of protein con-
tent were loaded per lane. Proteins were separated in
12 % polyacrylamide gel and visualized by Coomassie
Brilliant Blue (CBB-R250, Serva, Heidelberg, Germany)
staining or electrophoretically transferred onto PVDF
membrane (Immobilon-P Transfer Membrane, Millipore,
Bedford, USA), essentially according to the method of
Towbin et al. [28]. Molecular masses of the proteins were
estimated by comparison with the Precision Plus Protein
Standard Dual colour (BioRad, Prague, Czech Republic)
running in parallel.
Isoelectric focusing
All chemicals, solutions, strips and Ettan IPGphor sys-
tem for electrophoretic protein separation in the first di-
mension were purchased from GE Healthcare (Uppsala,
Sweden).
The sperm sample, 150 μg (for pH range 3–10) or
200 μg (for pH range 4–7) of protein in total volume of
180 μl of RHB freshly supplemented with 1 % (w/v)
dithiotreitol and 2 % (v/v) IPG buffer (pH 3–10, Amer-
sham Biosciences, Uppsala, Sweden), was applied to a
7 cm long strip (Immobiline Drystrip) and passively
rehydrated overnight at RT. Proteins were focused
for approx. 5 h with 50 mA per strip as follows: 150 V
for 50 min, 150–300 V for 1 h (gradient), 300–1000 V
for 30 min (gradient), 1000 V for 20 min, 1000–5000 V
for 1 h and 20 min (gradient), 5000 V as long as 8000
Vh in total were achieved.
After focusing the strips were incubated in equilibration
buffer (EB, 6 M urea, 50 mM Tris–HCl buffer pH 6.8,
30 % (v/v) glycerol, 2 % (w/v) SDS, 0.002 % w/v bromo-
phenol blue), containing 2 % (w/v) dithiotreitol for 15 min
and with 1 % (w/v) iodoacetamide in EB for 15 min. Strips
were laid onto a 12 % polyacrylamide slab gel for the
second-dimension electrophoresis (2D PAGE).
Immunodetection
Blots with an identical set of proteins were incubated in
PBST solution (0.05 % Tween 20 (v/v) in PBS) supple-
mented with 3 % gelatin overnight at 4 ° C and afterwards
incubated separately for 1 h at RT with undiluted or
PBST-diluted hybridoma supernatants (1:1). As a control,
the supernatant of Sp2/0 cells (null supernatant) was used.
After six 10-min washes in PBST, horseradish peroxidase
(HRP)-conjugated goat anti- mouse antibody (GAM/Px,
diluted 1:3000, BioRad, Prague, Czech Republic) was
applied for 1 h at RT. After that the blots were again in-
tensively washed (1 h, 10 PBST exchanges) and the reac-
tion of antibodies (the corresponding protein bands or
spots) was developed with SuperSignal West Pico chemi-
luminescent substrate (Pierce, Rockford, USA).
Alternatively, the membrane was developed in the
dark at room temperature with 0.05 % (w/v) 4-chloro-1-
naphtol (Serva, Heidelberg, Germany), 0.001 % (w/v)
CoCl2 and 0.09 % (v/v) hydrogen peroxide in 0.01 M
Tris–HCl (pH 7.4). The reaction was stopped after
10 min by washing the membrane in distilled water.
Relative molecular masses of proteins detected by
monoclonal antibodies were estimated by comparison
with the mobility of molecular mass protein standards
running in parallel after staining of blots with Coomassie




Gels intended to mass spectrometry were incubated
for 1 h at room temperature in a solution containing
CBB-R250, and in the solution of 35 % ethanol, 10 %
CH3COOH until the background disappeared and the
separated proteins in 2D PAGE were clearly and
sharply visible.
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Sample preparation and proteolytic digestion
All chemicals for sample preparation and mass spectro-
metric analysis were purchased from Sigma-Aldrich (St
Louis, MO, USA).
CBB-R250-stained protein spots of interest were ex-
cised from the gel and decolorized several times in sonic
bath at 60 °C with 10 mM dithiothreitol, 0.1 M 4-
ethylmorpholine acetate (pH 8.1) in 50 % acetonitrile
(ACN) until complete destaining. Then the gel was
washed with water, shrunk by dehydration with ACN
and reswollen by incubation in 60 mM iodoacetamide,
0.1 M 4-ethylmorpholine acetate (pH 8.1) for half an
hour in the dark at RT. After cysteine alkylation, the gel
was washed with water, shrunk by dehydration with
ACN and reswollen in water. The rehydration and dehy-
dration of the gel was repeated three times. Next, the gel
was reswollen in 0.05 M 4-ethylmorpholine acetate
(pH 8.1) in 50 % ACN and partly dried using a SpeedVac
concentrator (Savant, Holbrook, NY, USA). Finally, the
gel was reconstituted with cleavage buffer containing
0.01 % 2-mercaptoethanol, 0.05 M 4-ethylmorpholine
acetate, 10 % ACN, and sequencing grade trypsin
(Promega, 50 ng/μl). Digestion was carried out over-
night at 37 °C, and the resulting peptides were ex-
tracted with 30 % ACN/0.1 % trifluoroacetic acid and
subjected to mass spectrometric analysis.
MALDI/FT-ICR MS (Matrix Assisted Laser Desorption/
Ionization Fourier Transformed Ion Cyclotron Resonance
Mass Spectrometry)
Masses of individual peptides obtained after tryptic diges-
tion of Hs-14-detected protein(s) were determined by the
peptide mass fingerprint. Mass spectra of peptides were
measured using a MALDI/FT-ICR mass spectrometer
(9.4 T APEX-Qe, Dual ion source II, Bruker Daltonics,
Billarica, U.S.A.), a peptide map(s) was (were) estab-
lished, and mass spectra were searched against the
human Swissprot database using Mascot 2.3 software
(Matrix Science). The spectrum was calibrated internally
using the monoisotopic [M +H]+ ions of trypsin autopro-
teolytic products. A saturated solution of α-cyano-4-hy-
droxy-cinnamic acid in 50 % ACN/0.2 % TFA was used as
a MALDI matrix. One μl of matrix solution was mixed
with 1 μl of the sample on the target and the droplet was
allowed to dry at ambient temperature. The mass accuracy
was set to less than 3 ppm for the data interpretation.
Statistical analysis
Experimental data were analysed using GraphPad Prism
5.04. The differences between the normozoospermic and
asthenozoospermic group in the number of Hs-14-
positive cells were analysed by two-tailed Mann Whitney
test. The p value equal to or lower than 0.05 was consid-
ered to be significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
Results
Hs-14 monoclonal antibody
By fusion of immune spleen cells with Sp2/0 myeloma
cells we obtained 80 independently derived clones. One
of the positive clones, D5A12, generated the hybridoma
producing monoclonal antibody designated Hs-14. Ana-
lysis of immunoglobulin class showed that the Hs-14
antibody belongs to IgM molecules.
Immunofluorescent localization of the antigen recognized
by the Hs-14 mAb
Indirect immunofluorescence of samples of spermatozoa
with Hs-14 mAb demonstrated intensive staining of acro-
somes. The Hs-14 mAb strongly labelled the acrosome in
60–90 % ejaculated spermatozoa after permeabilization of
the cell membrane of samples from normozoospermic
men (Fig. 1a, 1b). The immunofluorescence showed that
the antibody also labelled the flagellum (Fig. 1b). This het-
erogeneous labelling was not visible in all tested samples.
The staining of the flagellum was obvious only in a low
number of cells or not at all. The intra-acrosomal
localization of the Hs-14-corresponding protein was con-
firmed by examination under confocal laser scanning
microscope. Digitized images of serial optical 3 μm-thick
sections of spermatozoa showed the most intensive stain-
ing from the 3rd to the 5th section (Fig. 1c). The samples
from asthenozoospermic men showed the same staining,
but the numbers of sperm were lower (not shown).
Western blot analysis of human sperm protein(s)
detected by the Hs-14 mAb
The pattern of immunoreactive human sperm proteins
observed in Western blots of 12 % gels is shown in Fig. 2.
Under non-reducing conditions the Hs-14 mAb showed
a strong signal at high molecular weight at approxi-
mately 240 kDa (p240) (Fig. 2a). In most Western blots
a weaker reaction of Hs-14 with a protein band of ap-
proximately 110 kDa (p110) was also observed. When β-
mercaptoethanol (2-ME) was used to reduce disulphide
bonds, protein bands with mobility corresponding ap-
proximately to 240, 110, 90–97 and 50–55 kDa appeared
(Fig. 2b). The same results were observed with RHB
sperm extracts (Fig. 2c). Control Western blots incu-
bated with supernatant of Sp2/0 myeloma cells (null
supernatant) and with an antibody of irrelevant specifi-
city (Prog.13, anti-progesterone) displayed no immuno-
reactive proteins (not shown).
Identification of the Hs-14-corresponding proteins by
MALDI mass spectrometry
To identify proteins reacting with the Hs-14 mAb on
Western blot, corresponding protein spots were found
on 2D gel (Fig. 3a), excised and subjected to MALDI/
FT-ICR MS. Mass spectra of peptides were measured
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and searched against the Swissprot database using Mas-
cot software. Two proteins were identified by peptide
mass fingerprint as TERA and β-tubulin. The protein
corresponding to TERA was independently identified
two times (from two different gels) and the sequence
coverage was 40.8 and 55.8 %, respectively. The
theoretical molecular weight (90 kDa) and isoelectric
point of 5.0 fit well the experimental 2D PAGE data.
The sequence coverage for β-tubulin was 62.7 %. The
theoretical molecular weight (50 kDa) and isoelectric
point of 4.6 fit well the experimental 2D PAGE data as
well. The Hs-14 reaction with another two proteins—of
about 240 and 110 kDa—was visible after 2D electro-
phoresis on some Western blots only, nevertheless, their
counterparts were not found on 2D gels. Therefore,
these two proteins were analysed by MALDI/FT-ICR
MS from the 1D gel (Fig. 3b). The protein of about
240 kDa was determined as a fibronectin precursor with
sequence coverage 24.7 %, theoretical molecular weight
266 kDa and isoelectric point 5.4. The protein of about
110 kDa could not be identified. Identification of TERA
by MALDI mass spectrometry is presented in Additional
file 1: Figure S1.
Comparison of anti-TERA and Hs-14 reaction with human
sperm extract
Recognition of TERA by the Hs-14 mAb was verified
using commercial anti-VCP (anti- TERA) monoclonal
antibody. On the immunoblot with human sperm ex-
tract separated by 2D PAGE, the Hs-14 antibody
(Fig. 4a) labelled the same spot as anti-TERA antibody
(Fig. 4b).
Nevertheless, the Hs-14 reaction and the anti-TERA
reaction were not quantitatively identical. The Hs-14
mAb reacted on blots with TERA more weakly than
the monospecific anti-VCP antibody. However, the
anti-TERA antibody reacted with differing intensity
with various human sperm extracts and the Hs-14
mAb copied the intensity of reactions with anti-TERA
(Fig. 5).
Fig. 2 Immunoblots of human sperm extracts with Hs-14 mAb. On
WB with SDS extract the antibody recognized a protein band of
about 240 kDa and a weak protein band of about 110 kDa under
non-reducing conditions (a). Under reducing conditions, two new
bands of about 95 and 55 kDa appeared (b). On WB with RHB
extract the antibody recognized the same protein bands (c). In some
reduced extracts the band of about 55 kDa was lacking (not shown).
Molecular mass markers (Mr × 103) are shown in the margins
Fig. 1 Immunostaining of representative samples of human ejaculated spermatozoa with Hs-14 monoclonal antibody and corresponding phase-
contrast microphotographs. The antibody strongly labelled sperm acrosome (a, b). In some samples, apart from the acrosome, the flagellum of
spermatozoa was also stained (b). Pictures of a series of 3-μm distributed sections of sperm cell in confocal microscope. The 3rd to the 5th
sections show the highest staining (c). Blue colour – DAPI staining of the nucleus, green colour – FITC staining (Fig. 1a and 1b magnification 600×,
Fig. 1c magnification 1000×)
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Reaction of Hs-14 and anti-tubulin mAbs with purified
tubulin
Recognition of tubulin with the Hs-14 mAb was confirmed
by reaction with purified tubulin. The purified tubulin was
separated electrophoretically on 7 % polyacrylamide gel,
and on Western blot with the transferred tubulin the Hs-14
and TU-06 antibodies reacted identically. More precisely,
they bound to the β-tubulin subunit while the TU-01 anti-
body reacted with α-tubulin and had no counterpart in the
Hs-14 reaction (Fig. 6).
Fig. 3 2D electrophoresis in RHB of human sperm extract and immunoblot with Hs-14 mAb (a). Isoelectric focusing was carried out in pH 3–10, and the
separation in the second dimension was run in 12 % polyacrylamide gel. On the corresponding blot the Hs-14-reacting proteins are indicated by arrow-
s and were subjected to mass spectrometry. In some cases the Hs-14 mAb reacted on WB also with proteins of about 240 and 110 kDa, but these proteins
had no counterparts in 2D gels. Therefore, the 240 kDa band for MS was selected from SDS PAGE according to the corresponding immunoblot (b)
Fig. 4 2D electrophoresis in RHB of human sperm extract and immunoblot with antibody Hs-14 (a) and immunoblot with anti-TERA mAb (b).
The protein spot reacting with antibody is marked on CBB-stained PVDF membrane with an arrow
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Immunodetection of the human sperm proteins with
diluted Hs-14 mAb
At the highest dilution of the Hs-14 antibody (Hs-14
supernatant, 1:500), the strongest antibody reaction on
Western blot with separated RHB human sperm extract
was again with the 95 kDa protein that was determined
by MALDI/FT-ICR MS as TERA. The reaction with the
approximately 110 kDa protein band completely disap-
peared and reactions with the bands of approximately
240 and 50 kDa were very weak (Fig. 7).
Expression of the Hs-14-reacting protein(s) in the sperm
of normozoospermic and asthenozoospermic men
Permeabilized spermatozoa of 30 individual samples from
the groups of both normozoospermic and asthenozoos-
permic men displayed different expression of the Hs-14
reacting protein(s) in indirect immunofluorescence (Fig. 8).
Asthenozoospermic men had a significantly lower count
of sperm labelled with the Hs-14 antibody compared to
normozoospermic men. The statistical difference was
evaluated by two-tailed Mann Whitney test and was sig-
nificant at 0.1 % level (P value < 0.001).
Discussion and conclusion
The Hs-14 monoclonal antibody was proved successful in
the assessment of human semen quality [8, 9]. A signifi-
cant positive correlation was found between the Hs-14-
detected protein(s) on the sperm and the semen quality.
To characterize the antibody we applied indirect im-
munofluorescence, biochemical methods and mass spec-
troscopy. Further, using the Hs-14 antibody we investigated
the relevant proteins on the sperm from men with normo-
zoospermia and asthenozoospermia.
Based on our results, we can conclude that the Hs-14
monoclonal antibody is not monospecific but binds sev-
eral proteins or similar epitopes of these proteins. After
one-dimensional electrophoresis, the antibody recog-
nized four protein bands of about 240, 110, 95 and
50 kDa on the immunoblot. After sperm sample separ-
ation in two-dimensional electrophoresis, two protein
spots reacting with the Hs-14 mAb were found on the
blot. Molecular masses of these spots were about 95 and
55 kDa, and mass spectrometric analysis identified these
proteins as transitional endoplasmic reticulum ATPase
(TERA) and tubulin, respectively. These results were
Fig. 5 Reactions of Hs-14 antibody and anti-TERA antibody with
different human sperm extracts RHB (columns 1, 2) and Triton X-100
(column 3) on immunoblot. These different sperm extracts were two
times loaded on the same electrophoretic gel. After western blotting
the membrane was divided into two halves and at each half were
given two different antibodies (Hs-14, TERA)
Fig. 6 Reaction of monoclonal antibodies Hs-14 and anti-tubulin antibodies (TU-06 and TU-01), and supernatant Sp2/0 (negative control) on
Western blot with purified tubulin. Hs-14 and TU-06 antibodies bound the N-terminal domain of β-tubulin
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obtained repeatedly with different samples. The two
remaining proteins—of 240 and 110 kDa—were not
identified on the gel after 2D electrophoresis. One of
these proteins, of 240 kDa, was extracted from the gel
after 1D electrophoresis and sequenced, and was identi-
fied as a fibronectin precursor. Nevertheless, protein se-
quencing from the 1D gel has limitations.
The participation of these three proteins in fertility has
already been investigated and their role was found to be
highly significant.
Fibronectin (Fn) is an adhesive molecule that binds to
β1, 3 and 4 integrins on the sperm surface [29] and
immunofluorescence revealed a broad distribution pat-
tern of Fn on the sperm heads [30]. In human sperm, Fn
has various functions: it activates the proteasome and in-
duces the acrosomal reaction [31], participates in the
sperm-egg interaction [32], and increased Fn concentra-
tion is associated with decreased sperm motility and
thus with fertility problems in men [33, 34].
Tubulin is the main structural element of the cell cyto-
skeleton. In mature spermatozoon tubulin is localized in
two major compartments: flagellum and head [26, 35, 36].
The flagellum is composed of a typical arrangement
of microtubules and is the organ of sperm motility
[35], which is closely related to sperm fertility. Our
previous study revealed differences in the amount of
β-tubulin among men with normozoospermia and
pathological spermiograms [37].
Transitional endoplasmic reticulum ATPase (TERA) is
a glycoprotein that is involved in membrane fusion and
presentation of ubiquitinated proteins to the proteasome
[38]. TERA is found in the sperm of different species
and is a substrate of cAMP-activated sperm tyrosine kin-
ase [39]. In human sperm TERA is one of the proteins
that are phosphorylated during capacitation [40]. Re-
cently, TERA was identified as one of the targets of
post-translational modification, sumoylation in the
sperm [41]. Sumoylation gives rise to small ubiquitin-
like modifiers (SUMO) that are implicated in the regula-
tion of numerous cellular events and also in the matur-
ation and differentiation of sperm [41].
Thus, each of these proteins can affect the sperm abil-
ity to fertilize eggs. We tried to find whether Hs-14 spe-
cifically recognizes all the three proteins that were
identified by mass spectrometry and is polyspecific or
whether the Hs-14 reactivity is partially caused by non-
specific cross-reactivity or the reaction with similar epi-
topes of these proteins. Some characteristics of the rele-
vant proteins indirectly exclude specific reaction with
the Hs-14 antibody. The concentration of fibronectin on
the sperm surface is negatively correlated with the sperm
motility [33, 34], while the number of spermatozoa la-
belled with Hs-14 is positively correlated with the sperm
quality. Immunofluorescent examination of spermatozoa
by confocal microscopy also demonstrated intracellular
localization of the target protein, while fibronectin is a
spermadhesive protein.
The mass spectrometry determination of tubulin
recognition by Hs-14 was verified by direct reaction
of Hs-14 with purified tubulin on Western blot and
β − tubulin was confirmed as one of the Hs-14-
reacting proteins. However, in immunofluorescence
the antibody labelled the flagellum, where tubulin is
located, less often than in the acrosome or not at all.
This knowledge also supports non-specific Hs-14 re-
action with tubulin.
Fig. 7 Immunodetection of human sperm proteins with diluted
Hs-14 mAb. At the highest Hs-14 antibody dilution (1:500), the reaction
with 95 kDa protein (TERA) was the strongest
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The Hs-14 specificity was also investigated after its dilu-
tion. At 500× dilution, the antibody reacted considerably
more strongly with TERA than with β-tubulin and fibro-
nectin. This reaction indicated TERA as the most probable
Hs-14-specific protein, while Hs-14 reaction with β-tubulin
and fibronectin suggested nonspecific cross-reactivity.
In addition, the reaction of monoclonal anti-TERA
and Hs-14 antibodies with various independently pre-
pared sperm extracts indicates TERA as the Hs-14
specific protein. Both antibodies consistently labelled
the same band of about 95 kDa on Western blots.
Only in the case of the strongest sperm extract
(Fig. 7) Hs-14 labelled additional bands.
We also wanted to identify the Hs-14 target protein by
immunoprecipitation of human sperm lysate with the
Hs-14 antibody. For the experiment we used a direct im-
munoprecipitation kit (Pierce Protein Biology product)
according to the manufacturer’s instructions, in which
the relevant antibody (Hs-14) was covalently bound to
aldehyde-activated beaded agarose resin and sperm pro-
tein lysate was added. Unfortunately, we did not obtain
an unequivocal result. The following electrophoresis did
not determine one protein only and it also supported
Hs-14 nonspecific cross-reactivity with several proteins.
Similar results were obtained by a classical immunopre-
cipitation test with protein A.
The other reason for the difficulty in unequivocally
identifying the Hs-14 target protein can be the complex
IgM nature of the Hs-14 antibody. IgM antibodies are
frequently associated with unspecific cross-reactivity,
and therefore are generally less reliable.
As mentioned above, the basic aim of this study was to
identify the Hs-14-recognized protein(s), because the anti-
body proved to be a good marker for sperm quality
evaluation [8]. In our previous investigations we followed
the differences among normozoospermic and pathological
sperm mainly with severe damage. Here we utilized the
antibody and concentrated on the differences between
normozoospermic and asthenozoospermic men found by
the Hs-14 antibody. Spermatozoa of asthenozoospermic
men are seemingly of good quality, with normal morph-
ology, and the sperm concentration in asthenozoospermic
ejaculates is also normal (>15 × 106 cells per ml) [1]. The
only apparent defect is their decreased motility. Still, many
asthenozoospermic patients are sterile or subfertile and
this deficiency can be circumvented by in vitro fertilization
using intracytoplasmic sperm injection.
Monitoring of asthenozoospermic and normozoos-
permic samples showed decreased Hs-14 protein ex-
pression in 15 out of 30 asthenozoospermic men
(<60 % labelled cells), while only three out of 30
followed normozoospermic individuals displayed less
than 60 % labelled cells. Statistical analysis showed a
significant difference (P < 0.001) in the number of Hs-
14- positive spermatozoa between both groups.
Our data showed decreased expression of relevant
sperm protein TERA (formerly VCP) in asthenozoos-
permic men. Recently, TERA was identified as a pro-
tein playing a role in ubiquitination [41]. Decreased
detection of this protein in asthenozoospermic men
can most probably be explained by spontaneous acro-
some reaction, which may occur in ejaculated sperm
or impaired synthesis of the protein in the sperm
with pathological spermiograms.
Conclusion
Our data suggest transitional endoplasmic reticulum
ATPase (TERA - formerly VCP) as target protein of Hs-
Fig. 8 Hs-14 mAb-labeled spermatozoa in 30 sperm samples originated from men with normal spermiograms (N) and 30 samples from men with
asthenozoospermia (A) Columns represent the average percentage of spermatozoa with Hs-14 labelling of acrosome, each sample was evaluated
three times. (a). The difference in the number of Hs-14-positive cells between men with normozoospermia and asthenozoospermia was evaluated by
two-tailed Mann Whitney test and was significant (p≤ 0.001) (b). Middle lines indicate the arithmetic means, bars denote the standard deviations (SD),
and whiskers indicate minimum and maximum of the values
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14 monoclonal antibody and revealed decreased expres-
sion of TERA in asthenozoospermic men in comparison
with normozoospermic ones. We can conclude that ap-
propriate monoclonal antibodies against sperm can be
used not only as biomarkers of sperm quality, but also
for detection of sperm defects at the molecular level.
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